- Report
- March 2025
- 149 Pages
Global
From €2662EUR$2,999USD£2,300GBP
- Report
- January 2025
- 132 Pages
Global
From €2662EUR$2,999USD£2,300GBP
- Report
- March 2025
- 200 Pages
Global
From €2210EUR$2,490USD£1,909GBP
- Report
- January 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- January 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- July 2025
- 150 Pages
Global
From €3417EUR$3,850USD£2,952GBP
€4304EUR$4,850USD£3,719GBP
- Report
- July 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- July 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more